Expand IMNM Menu
IMNM MENU

IMNM Stock Summary and Trading Ideas (Immunome | NASDAQ:IMNM)

Charts for Today's Stock Price and Implied Volatility in Immunome

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for IMNM by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Immunome (IMNM) Frequently Asked Questions

What does Immunome do?

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.

What symbol and exchange does Immunome stock trade?

Immunome trades on the NASDAQ stock market under the symbol IMNM.

What is Immunome stock price doing today?

As of April 25, 2024, IMNM stock price climbed to $14.44 with 136,791 million shares trading.

What is Immunome's Beta?

IMNM has a beta of 1.32, meaning it tends to be more sensitive to market movements. IMNM has a correlation of 0.03 to the broad based SPY ETF.

How much is Immunome worth?

IMNM has a market cap of $856.91 million. This is considered a Small Cap stock.

How much money does Immunome make?

Last quarter Immunome reported $4 million in Revenue and -$.15 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.13.

What is the highest and lowest price Immunome traded in the last 3 year period?

In the last 3 years, IMNM stock traded as high as $32.45 and as low as $2.09.

What are the top ETFs holding Immunome?

The top ETF exchange traded funds that IMNM belongs to (by Net Assets): VTI, VXF, DWAS, PTH, IWC.

Is Immunome (IMNM) a good investment?

IMNM has outperformed the market in the last year with a return of +172.5%, while the SPY ETF gained +22.7%. However, in the most recent history, IMNM shares have underperformed the stock market with its stock returning -5.7% in the last 3 month period and -29.0% for the last 2 week period, while SPY has returned +3.2% and -2.9%, respectively.

What is the support and resistance for Immunome (IMNM) stock price?

IMNM support price is $13.52 and resistance is $15.02 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IMNM stock will trade within this expected range on the day.